Marshall Hargrave is a stock analyst and writer with 10+ years of experience covering stocks and markets, as well as analyzing and valuing companies. Cierra Murry is an expert in banking, credit cards ...
A research group at the Stowers Institute for Medical Research says it has put to rest the notion that a gene promoter is only a promoter. They report, in the current issue of eLife Sciences, that ...
Tumor agnostic efficacy and safety of erdafitinib (erda) in patients (pts) with advanced solid tumors with prespecified FGFR alterations (FGFRalt): RAGNAR primary analysis.
The working principle of so-called promoters in a catalytic process has been effectively seen in real-time for the first time by researchers at TU Wien. Although their significance in technology is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results